Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
1981-1-16
|
pubmed:abstractText |
The displacement of spiroperidol binding by the optical isomers of butaclamol in synaptosomal preparations of the caudate nucleus obtained from parkinsonians and non-parkinsonians at post mortem were investigated. A group of spiroperidol binding sites found in the non-parkinsonians was less strongly expressed or absent in analogous tissue of the parkinsonian. The significance of these findings in relation to Parkinson's disease and its treatment are discussed.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0303-6995
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
45-51
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:6159454-Binding, Competitive,
pubmed-meshheading:6159454-Butaclamol,
pubmed-meshheading:6159454-Butyrophenones,
pubmed-meshheading:6159454-Caudate Nucleus,
pubmed-meshheading:6159454-Humans,
pubmed-meshheading:6159454-Parkinson Disease,
pubmed-meshheading:6159454-Spiperone,
pubmed-meshheading:6159454-Synaptic Membranes
|
pubmed:year |
1980
|
pubmed:articleTitle |
Spiroperidol binding in the human caudate nucleus.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.
|